The company was founded over one year ago, and has obtained initial VC funding of 43 million yuan.Small molecule medicine and cell therapy products, two categories and four pipelines.One small molecule (topical ointment) is expected to enter Phase I trial in 2024.
描述
XML 地图 | Sitemap 地图